Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds-Reference-Cited by-同舟云学术

Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds

Published:2023-02 Issue: Volume:225 Page:115219
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Jyrkäs Juha,Lassila Toni,Tolonen Ari

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference33 articles.

1. Therapeutic peptides: technological advances driving peptides into development;Sato;Curr. Opin. Biotechnol.,2006

2. Peptide therapeutics: Current status and future directions;Fosgerau;Drug Discov. Today,2015

3. The Future of Peptide-based Drugs;Craik;Chem. Biol. Drug Des.,2013

4. Overcoming poor permeability: translating permeation enhancers for oral peptide delivery;Maher;Drug Discov. Today Technol.,2012

5. Strategic Approaches to Optimizing Peptide ADME Properties;Di;AAPS J.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism of new drug modalities research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-05

2. The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development;Pharmacological Research;2023-09

3. Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations;Drug Metabolism and Disposition;2023-08-17

4. Meeting report: DMDG peptide and oligonucleotide ADME workshop 2022;Xenobiotica;2023-04-03